XML 110 R88.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity - Additional Information (Detail) - USD ($)
12 Months Ended 60 Months Ended
Apr. 01, 2018
Oct. 27, 2017
Sep. 30, 2017
Aug. 31, 2018
Aug. 31, 2017
Aug. 31, 2016
Aug. 31, 2018
Jan. 05, 2018
Stockholders Equity Note [Line Items]                
Shares available for grant       1,050,675 233,271 476,770 1,050,675  
Performance based share based compensation       317,036 269,705 447,895    
Share based compensation, non vested shares       467,710     467,710  
Additional shares available for grant       467,710        
Unamortized compensation cost of restricted stock grants       $ 15,500,000     $ 15,500,000  
2018 Senior Notes                
Stockholders Equity Note [Line Items]                
Conversion of 2018 Convertible Senior Notes, shares 3,400,000              
Debt instrument, maturity date       Apr. 01, 2018        
2017 Amended and Restated Stock Incentive Plan                
Stockholders Equity Note [Line Items]                
Number of shares reserved for future issuance               1,100,000
Maximum aggregate number of common shares authorized for issuance               5,425,000
Selling, Administrative and Cost of Revenue                
Stockholders Equity Note [Line Items]                
Restricted stock compensation expense       $ 17,200,000 $ 20,200,000 $ 22,500,000    
Share Repurchase Program - 2014                
Stockholders Equity Note [Line Items]                
Repurchase of common stock, shares       0 0   3,206,226  
Stock repurchase program total cost of repurchased shares             $ 137,000,000  
Remaining authorized repurchase amount       $ 88,000,000     88,000,000  
Repurchase program expiration date   Mar. 31, 2019 Jan. 01, 2018 Jan. 01, 2018        
Maximum | Share Repurchase Program - 2013                
Stockholders Equity Note [Line Items]                
Amount authorized for repurchase       $ 225,000,000     $ 225,000,000  
Unvested Restricted Stock Grants                
Stockholders Equity Note [Line Items]                
Share based compensation, non vested shares       788,744 837,654   788,744  
Fair value of awards granted       $ 15,200,000 $ 11,300,000 $ 12,500,000    
Restricted Stock | Minimum                
Stockholders Equity Note [Line Items]                
Vesting period of compensation expense       1 year        
Restricted Stock | Maximum                
Stockholders Equity Note [Line Items]                
Vesting period of compensation expense       3 years